Literature DB >> 25782638

Phenotype-genotype correlations for clinical variants caused by CYLD mutations.

Nikoletta Nagy1, Katalin Farkas2, Lajos Kemény3, Márta Széll4.   

Abstract

Brooke-Spiegler syndrome (BSS; OMIM 605041) is an autosomal dominant condition characterized by skin appendageal neoplasms including cylindromas, trichoepitheliomas, and/or spiradenomas. In 1996, the gene locus for BSS was mapped to 16q12-13, and, in 2000, mutations in the cylindromatosis (CYLD) gene were determined to cause BSS, familial cylindromatosis (FC; OMIM 132700) and multiple familial trichoepithelioma type 1 (MFT1; OMIM 601606). The CYLD gene encodes an enzyme with deubiquitinase activity. To date, a total of 95 different diseases-causing mutations have been published for the CYLD gene. A summary of mutations identified in Hungarian patients and a review of previously published mutations are presented in this update. The majority of the sequence changes are frameshift (48%), nonsense (27%), missense (12%) and splice-site (11%) mutations; however, two in-frame deletions have also been reported. Most mutations are located in exons 9-20. Analysis of the identified CYLD gene mutations and the observed BSS, FC and MFT1 clinical phenotypes of the patients revealed significant genotype-phenotype correlations. Elucidation of these genotype-phenotype correlations is critical for the diagnosis of these rare monogenic skin diseases. In addition, characterizing these correlations may promote the understanding of their mechanisms and may hopefully contribute to the development of future therapeutic modalities.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Brooke-Spiegler syndrome; Cylindromatosis gene; Familial cylindromatosis; Familial trichoepitheliomatosis; Mutation update

Mesh:

Substances:

Year:  2015        PMID: 25782638     DOI: 10.1016/j.ejmg.2015.02.010

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  14 in total

1.  Multiple Facial Trichoepitheliomas and Vulval Cysts: Extending the Phenotypic Spectrum in CYLD Cutaneous Syndrome.

Authors:  Anna Dubois; Angel Alonso-Sanchez; Vrinda Bajaj; Akhtar Husain; Neil Rajan
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

2.  Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines.

Authors:  Ceyda Çalışkan; Melek Pehlivan; Zeynep Yüce; Ogun Sercan
Journal:  Mol Biol Rep       Date:  2017-08-24       Impact factor: 2.316

3.  A large family with CYLD cutaneous syndrome: medical genetics at the community level.

Authors:  Anderson Pontes Arruda; Augusto César Cardoso-Dos-Santos; Luiza Monteavaro Mariath; Mariléa Furtado Feira; Thayne Woycinck Kowalski; Kalina Ribeiro Fontenele Bezerra; Leonardo Augusto Coelho Torres da Silva; Erlane Marques Ribeiro; Lavinia Schuler-Faccini
Journal:  J Community Genet       Date:  2019-12-03

Review 4.  Macrophages and the Recovery from Acute and Chronic Inflammation.

Authors:  Kajal Hamidzadeh; Stephen M Christensen; Elizabeth Dalby; Prabha Chandrasekaran; David M Mosser
Journal:  Annu Rev Physiol       Date:  2016-12-07       Impact factor: 19.318

5.  Multiple familial trichoepithelioma: confirmation via dermoscopy.

Authors:  Cristián Navarrete-Dechent; Shirin Bajaj; Ashfaq A Marghoob; Sergio González; Daniel Muñoz
Journal:  Dermatol Pract Concept       Date:  2016-07-31

6.  Cutaneous Adnexal Cylindroma of Breast: Epithelial Immunoreactivities for GATA-3, Mammaglobin, and E-Cadherin Do Not Equate to a Mammary Ductal Neoplasm.

Authors:  A Halima; A M Pannunzio; E M Erstine; J S Ko; W F Bergfeld; R M Malaya; M B Frankel; B C Calhoun; C D Sturgis
Journal:  Case Rep Pathol       Date:  2018-02-13

7.  Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.

Authors:  Majid Arefi; Valerie Wilson; Siobhan Muthiah; Simon Zwolinski; Dalvir Bajwa; Paul Brennan; Katie Blasdale; David Bourn; John Burn; Mauro Santibanez-Koref; Neil Rajan
Journal:  J Am Acad Dermatol       Date:  2019-05-11       Impact factor: 11.527

8.  CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.

Authors:  Carol Dobson-Stone; Marianne Hallupp; Hamideh Shahheydari; Audrey M G Ragagnin; Zac Chatterton; Francine Carew-Jones; Claire E Shepherd; Holly Stefen; Esmeralda Paric; Thomas Fath; Elizabeth M Thompson; Peter Blumbergs; Cathy L Short; Colin D Field; Peter K Panegyres; Jane Hecker; Garth Nicholson; Alex D Shaw; Janice M Fullerton; Agnes A Luty; Peter R Schofield; William S Brooks; Neil Rajan; Mark F Bennett; Melanie Bahlo; John E Landers; Olivier Piguet; John R Hodges; Glenda M Halliday; Simon D Topp; Bradley N Smith; Christopher E Shaw; Emily McCann; Jennifer A Fifita; Kelly L Williams; Julie D Atkin; Ian P Blair; John B Kwok
Journal:  Brain       Date:  2020-03-01       Impact factor: 15.255

9.  p63 and smooth muscle actin expression in low-grade spiradenocarcinomas in a case of CYLD cutaneous syndrome.

Authors:  Aoisha Hoyle; Kerry Davies; Neil Rajan; Lucy Melly
Journal:  J Cutan Pathol       Date:  2018-07-19       Impact factor: 1.587

10.  Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.

Authors:  Helen R Davies; Kirsty Hodgson; Edward Schwalbe; Jonathan Coxhead; Naomi Sinclair; Xueqing Zou; Simon Cockell; Akhtar Husain; Serena Nik-Zainal; Neil Rajan
Journal:  Nat Commun       Date:  2019-10-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.